Editorial Note: Olmesartan Potentiates the Anti-Angiogenic Effect of Sorafenib in Mice Bearing Ehrlich’s Ascites Carcinoma: Role of Angiotensin (1–7) 0 19.12.2024 17:00 Plos.org by The PLOS ONE Editors
